BDX 4.17% 12.5¢ bcal diagnostics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2

  1. 11,748 Posts.
    lightbulb Created with Sketch. 5949
    $9.5m Cash on Hand

    Multiple near term strategies for commercialisation

    Already demonstrated Management have Commercial ability to negotiate and Partner with significant players...

    Diagnostic Tests take large cohorts to test upon and seeking multiple ethnicities to gain statistically significant data is a clever early move for a Diagnostic Test with Global Potential..

    Trial trial trial trial trial , analyse the data , accuracy rate identified ,,,,,Commercialised immediate Revenue ..

    If this were an 800m race circa 200m to run ,,NZT

    Company has recovered swiftly with a 50% rise since late June ........ in fact 31 days = 50% gain
 
watchlist Created with Sketch. Add BDX (ASX) to my watchlist
(20min delay)
Last
12.5¢
Change
0.005(4.17%)
Mkt cap ! $39.28M
Open High Low Value Volume
12.0¢ 12.5¢ 12.0¢ $996 8.208K

Buyers (Bids)

No. Vol. Price($)
5 430424 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 183667 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
BDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.